The defects in energy metabolism that impair the ability to respond to increased energy needs in the brain and muscles during exercise appear to be crucial pathogenic mechanisms for PED due to SLC2A1 mutations and mitochondrial disorders (including defect of PDH complex, ECSH1 and HIBCH) and metabolic myopathies. Here, SLC2A1 is linked to metabolic myopathy.